Diagnosticos da America S.A.
11 May 2015
Available for Immediate Download
Diagnosticos da America S.A. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Diagnosticos da America S.A. required for business and competitor intelligence needs - Intelligence on Diagnosticos da America S.A.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Diagnosticos da America S.A., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Diagnosticos da America (DASA) is a medical diagnostics company, engaged in research and development of diagnostic tests and their application to the medical practice. The company also provides support services for around 5,024 laboratories. The company primarily operates in Brazil, where it is headquartered in Barueri, and employs around 19,272 people. The company recorded revenues of BRL2,487.5 million (approximately $1,159.5 million) in the fiscal year ended December 2013, an increase of 9.9% over 2012. The company's operating profit was BRL289.5 million (approximately $134.9 million) in fiscal 2013, an increase of 18.2% over 2012. Its net profit was BRL131.3 million (approximately $61.2 million) in fiscal 2013, an increase of 54.1% over 2012. Reasons to Purchase: - Gain understanding of Diagnosticos da America S.A. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Diagnosticos da America S.A. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Diagnosticos da America S.A. your competitors' business structure, strategy and prospects